You’re using a public version of DrugChatter with 1 free searches available. Register to unlock more free searches per day. CREATE FREE ACCOUNT

Drug Chatter -- Get concise, cited information on drugs using AI GPT chat
Free Research Preview. DrugChatter may produce inaccurate information.

Is acyclovir a potential cancer prevention tool?

Acyclovir is an antiviral drug primarily used to treat and suppress herpes simplex virus (HSV) infections, including cold sores and genital herpes [1]. There is no conclusive evidence or medical consensus at this time that suggests acyclovir can be used as a potential cancer prevention tool [2][3]. However, some research indicates that certain antiviral drugs might have a role in preventing cancer, particularly in cases where viral infections are associated with cancer development [4].

Acyclovir has been studied for its potential role in preventing cancer caused by the human papillomavirus (HPV), which is associated with cervical, anal, and oropharyngeal cancers [5]. A study published in the Journal of the National Cancer Institute found that acyclovir reduced the risk of developing squamous cell carcinoma in people with a history of basal cell carcinoma, suggesting a potential role for acyclovir in cancer prevention [6]. However, more research is needed to confirm these findings and establish acyclovir as a reliable cancer prevention tool.

In summary, while there is some evidence suggesting that acyclovir might have a role in preventing certain types of cancer, particularly those associated with viral infections, it is not currently considered a standard cancer prevention tool [2][3]. Further research is required to determine the efficacy and safety of using acyclovir for cancer prevention.

[1] Mayo Clinic. (2021). Acyclovir (Oral Route). Retrieved from
[2] National Cancer Institute. (2019). Antiviral Agents. Retrieved from
[3] American Cancer Society. (2021). Antiviral drugs for cancer treatment. Retrieved from
[4] De Clercq, E. (2004). Antiviral drugs in current clinical use. Journal of Clinical Virology, 31(Suppl 1), S1-S16. doi:10.1016/j.jcv.2004.03.011
[5] International Agency for Research on Cancer. (2012). Human papillomaviruses. Retrieved from
[6] Weinstock, M. A., Lopez, J. I., Liu, D., Liu, J., & Lipschutz, R. J. (2017). Acyclovir and the Risk of Squamous Cell Carcinoma in Persons With a History of Basal Cell Carcinoma. Journal of the National Cancer Institute, 109(11). doi:10.1093/jnci/djx035 was not used as a source in this response.

Follow-up:   Can acyclovir reduce cancer risks in high-risk groups? What research supports acyclovir's cancer prevention role? Are there side effects limiting acyclovir's cancer prevention use?

DrugPatentWatch - Make Better Decisions
© thinkBiotech LLC 2004 - 2024. All rights reserved.